Which has the lower trailing P/E, ANIP or INVA?

INVA has the lower trailing P/E: ANIP trades at 15.33 and INVA at 5.06. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ANIP or INVA?

Over the past five years, ANIP grew revenue faster — ANIP at a 35.61% CAGR versus INVA at 3.94%.

Is ANIP or INVA more profitable?

INVA runs the higher net margin — ANIP at 10.82% versus INVA at 80.56%.

How have ANIP and INVA total returns compared?

Over the past 10 years, ANIP delivered 0.51% and INVA delivered 6.43% annualized total return. Past performance doesn't predict future results.

ANI Pharmaceuticals, Inc. (ANIP) vs Innoviva, Inc. (INVA)

A side-by-side comparison of ANI Pharmaceuticals, Inc. and Innoviva, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ANIP

ANI Pharmaceuticals, Inc.

$1.61B

$71.00HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT

INVA

Innoviva, Inc.

$1.53B

$20.74HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT

Total return — ANIP vs INVA

growth of $100 · dividends reinvested · last 10y

ANIP +5.2% (+0.5%/yr)INVA +90.4% (+6.7%/yr)INVA compounded faster over this window

ANIP INVA

ANIP vs INVA: by the numbers

•ANIP is the larger company ($1.61B vs $1.53B market cap).
•INVA trades at the lower trailing earnings multiple (5.06 vs 15.33 P/E), one valuation lens rather than an overall verdict.
•INVA converts more revenue to profit (80.56% vs 10.82% net margin).
•ANIP grew revenue faster over the past five years (35.61% vs 3.94% CAGR).

Metrics side by side

Valuation

Metric	ANIP	INVA
P/E ratio	15.33	5.06
Forward P/E	7.65	8.57
PEG ratio	N/A	0.49
P/S ratio	1.65	3.45
P/B ratio	2.70	1.24
EV / EBITDA	6.71	4.87
FCF yield	N/A	12.30%

Profitability

Metric	ANIP	INVA
Gross margin	51.01%	73.09%
Operating margin	15.35%	36.66%
Net margin	10.82%	80.56%
ROE	17.72%	28.97%
ROIC	9.26%	8.36%

Growth (annualized)

Metric	ANIP	INVA
Revenue CAGR (5Y)	35.61%	3.94%
EPS CAGR (5Y)	N/A	12.71%
FCF CAGR (5Y)	N/A	-10.54%
Total return CAGR (5Y)	16.86%	4.52%

Frequently asked

Which has the lower trailing P/E, ANIP or INVA?: INVA has the lower trailing P/E: ANIP trades at 15.33 and INVA at 5.06. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ANIP or INVA?: Over the past five years, ANIP grew revenue faster — ANIP at a 35.61% CAGR versus INVA at 3.94%.
Is ANIP or INVA more profitable?: INVA runs the higher net margin — ANIP at 10.82% versus INVA at 80.56%.
How have ANIP and INVA total returns compared?: Over the past 10 years, ANIP delivered 0.51% and INVA delivered 6.43% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ANIP analysis Full INVA analysis Interactive comparison tool

Dig into the metrics

ANI Pharmaceuticals P/E ratio Innoviva P/E ratio ANI Pharmaceuticals ROE Innoviva ROE ANI Pharmaceuticals operating margin Innoviva operating margin ANI Pharmaceuticals revenue growth Innoviva revenue growth ANI Pharmaceuticals free cash flow Innoviva free cash flow

ANI Pharmaceuticals & Innoviva appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.